All Industries

Top pharmaceuticals Companies

14 pharmaceuticals companies, sorted by total funding raised.

BridgeBio PharmaIPO

BridgeBio Pharma is a clinical-stage biopharmaceutical company developing therapies for genetic d...

Palo Alto, United States501–1000healthtech, biotech
Growth Equity·$1.2B·Jan 2024
Crinetics Pharmaceuticals, Inc.

R&D company with 6 SBIR/STTR awards from Department of Health and Human Services.

San Diego, United States11–50Biotech, Healthcare
Venture Unknown·$453.5M·Jan 2026
Rhythm PharmaceuticalsIPO

Biotechnology company developing peptide therapeutics that address unmet needs in metabolic diseases

Boston, United States201–500pharmaceuticals, healthtech
Extension Round·$398.0M·Jul 2025
Larimar TherapeuticsIPO

Clinical-stage biotech developing treatments for complex rare diseases, with lead compound target...

Bala Cynwyd, United States51–200healthtech, biotech
Venture Unknown·$80.0M·May 2020
EyePointIPO

Clinical-stage biotech developing innovative sustained-release therapeutics for serious retinal d...

Watertown, United States51–200manufacturing, biotechnology
Corporate Round·$60.5M·Mar 2018
Sorriso Pharmaceuticals

Sorriso Pharmaceuticals is a biotechnology company advancing a pipeline of disease-modifying anti...

Sandy, United States1–10biotech, pharmaceuticals
Series A·$31.0M·Dec 2021
NexchemAcquired

Leading Chinese producer of active pharmaceutical ingredients (API) for global markets

Jinhua, China11–50pharmaceuticals
Series A·$27.0M·Apr 2011
SavaraIPO

A clinical stage biopharmaceutical company focused on rare respiratory diseases.

Austin, United States51–200biotech, pharmaceuticals
Series B·$17.4M·Mar 2013
Rigel PharmaceuticalsIPO

Clinical-stage drug development company that discovers and develops novel, small-molecule drugs f...

South San Francisco, United States51–200pharmaceuticals, healthtech
Funding undisclosed
Dura PharmaceuticalsAcquired

Synthetic peptides for treatment of allergies and asthma

San Diego, United Statespeptides, pharmaceuticals
Funding undisclosed
HarrowIPO

Ophthalmic pharmaceutical company providing disease management solutions in North America. Nasdaq...

Nashville, United Stateshealthtech, pharmaceuticals
Funding undisclosed
Haleon plcIPO

British multinational consumer healthcare company focused on everyday health products including S...

Weybridge, United Kingdom10001+e-commerce, consumer healthcare
Funding undisclosed
Genor BiopharmaIPO

Innovation-driven biopharmaceutical company developing and commercializing oncology and autoimmun...

Shanghai, China201–500Biotech, biotech
Funding undisclosed
CorMedixIPO

Biopharmaceutical company developing and commercializing therapeutic products for prevention and ...

United Stateshealthtech, biotech
Funding undisclosed